Dr. Roderick Wong has withdrawn his slate of director nominees for election at Facet Biotech Corporation’s (NASDAQ:FACT) 2009 annual meeting of stockholders. Wong’s withdrawal means that our investment thesis is gone, and we’re closing the position.
We opened the position at $9.13 and closed it at $8.96, which means we’re down 1.86% on an absolute basis. [...]
Archive for the ‘Facet Biotech Corporation (NASDAQ:FACT)’ Category
Facet Biotech Corporation (NASDAQ:FACT) alternate slate withdrawn; Greenbackd exits
Posted in Activist Investors, Facet Biotech Corporation (NASDAQ:FACT), Robert. L. Chapman, Seth Klarman, Special Situation, Stocks, tagged Activist investment, Facet Biotech Corporation (NASDAQ:FACT) on May 7, 2009 | 4 Comments »
Special situation: Facet Biotech Corporation (NASDAQ:FACT)
Posted in Activist Investors, Baupost Group, Facet Biotech Corporation (NASDAQ:FACT), Robert. L. Chapman, Special Situation, Stocks, tagged Baupost Group, Facet Biotech Corporation (NASDAQ:FACT), Robert. L. Chapman, Seth Klarman, Special Situation on April 22, 2009 | 10 Comments »
Facet Biotech Corporation (NASDAQ:FACT) is a new category of investment for us: special situations. It’s an activist play with a catalyst in the form of Dr. Roderick Wong’s nomination for the annual meeting of an alternative slate of directors, including well-known activist investor Robert. L. Chapman. The dissident slate has called for a cash dividend [...]

